Literature DB >> 25182980

The baboon model of pertussis: effective use and lessons for pertussis vaccines.

Jason M Warfel1, Tod J Merkel.   

Abstract

The USA is experiencing a pertussis resurgence that resulted in a 60-year high of 48,000 cases in 2012. Our ability to counteract this resurgence is hampered by the fact that pertussis pathogenesis and immunity to pertussis infection are not well studied. Studies in humans are difficult due to the low frequency of pertussis in the population, the cyclical nature of incidence and the sporadic geographic distribution of cases. While existing animal models reproduce many aspects of pertussis, none of them adequately reproduces the full spectrum of disease. We describe the baboon model of pertussis. The baboon model is the first animal model that recapitulates the full spectrum of human pertussis including coughing and transmission. This model is being utilized to examine pertussis pathogenesis and host responses to infection and vaccination. It is likely the baboon model will provide an important tool in the development of improved pertussis vaccines.

Entities:  

Keywords:  T-cell memory; Th17; baboons; pertussis; vaccines; whooping cough

Mesh:

Substances:

Year:  2014        PMID: 25182980     DOI: 10.1586/14760584.2014.946016

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  28 in total

Review 1.  Contribution of pertussis toxin to the pathogenesis of pertussis disease.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

2.  The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.

Authors:  Jamie Jennings-Gee; Sally Quataert; Tridib Ganguly; Ralph D'Agostino; Rajendar Deora; Purnima Dubey
Journal:  Infect Immun       Date:  2018-05-22       Impact factor: 3.441

3.  Bordetella pertussis Adenylate Cyclase Toxin Disrupts Functional Integrity of Bronchial Epithelial Layers.

Authors:  Shakir Hasan; Nikhil Nitin Kulkarni; Arni Asbjarnarson; Irena Linhartova; Radim Osicka; Peter Sebo; Gudmundur H Gudmundsson
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

4.  Restricted MHC class I A locus diversity in olive and hybrid olive/yellow baboons from the Southwest National Primate Research Center.

Authors:  Rebecca A Morgan; Julie A Karl; Hailey E Bussan; Katelyn E Heimbruch; David H O'Connor; Dawn M Dudley
Journal:  Immunogenetics       Date:  2018-03-28       Impact factor: 2.846

5.  Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice.

Authors:  Kyle Caution; Kacy Yount; Rajendar Deora; Purnima Dubey
Journal:  J Vis Exp       Date:  2019-02-22       Impact factor: 1.355

6.  Highlights of the 12th International Bordetella Symposium.

Authors:  Camille Locht; Nicholas H Carbonetti; James D Cherry; F Heath Damron; Kathryn M Edwards; Rachel Fernandez; Eric T Harvill; Daniela Hozbor; Kingston H G Mills; Maria Eugenia Rodriguez; Françoise Mascart
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

Review 7.  What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

Authors:  Nicolas Burdin; Lori Kestenbaum Handy; Stanley A Plotkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

Review 8.  Pertussis vaccines and protective immunity.

Authors:  Parul Kapil; Tod J Merkel
Journal:  Curr Opin Immunol       Date:  2019-05-09       Impact factor: 7.486

9.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Clin Vaccine Immunol       Date:  2015-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.